Six people who traveled to Shanghai for CAR T-cell therapy, in their own words. The decision, the treatment, and what came after — told plainly.
Every patient's journey is unique — these are personal accounts, not a prediction of results for anyone else.
Facility & leadership · not a patient story
SinoUnited Health's leadership on why CAR T-cell therapy — and the multidisciplinary team behind every patient — sits at the center of the hospital's mission.
Program overview · with Dr. Lily Zhou and SUH leadership
Not through a search result — through a community group, a friend, or someone who had already made the trip to Shanghai. In their words:
A fellow myeloma patient on a Facebook page passed on Dr. Zhou's contact details.
Tim · New Zealand · Multiple myelomaA myeloma community page online — and a man who had recently been to Shanghai himself.
Emma · New Zealand · Multiple myelomaIt was reassuring having other Kiwis tell us of their experiences.
Irene · New Zealand · Relapsed non-Hodgkin lymphomaI got introduced to people on a similar cancer journey. They were all talking about Shanghai.
Dale · New Zealand · Stage 4B lymphomaA short eligibility check is the first step. It asks only for basic contact details and your diagnosis — your records are then reviewed by our hematology team.
Inside the CAR-T program · Dr. Lily Zhou and SinoUnited Health leadership